Funds to three areas. More than 40 billion will go to rebuilding after the earthquake and tsunami and to disaster prevention. Workers will use the funds repairing infrastructure such as tunnels and bridges. About 35 billion will be spent on measures to ensure security and revitalized communities. And about 35 billion will be spent on driving growth. Some of that will support business ventures. Other funds will go into promoting joint Research Projects between universities and companies. Stimulus package plus spending by local governments and the private sector will add up to 230 billion. Translator governments under the Democratic Party focused only on redistribution. They didnt make enough effort to increase incomes and expand the economy. Im determined to change the basic philosophy. Im going to boost the profits of Japanese Companies to create jobs and increase wages. Government leaders say the stimulus will help them create 600,000 jobs. They say theyll push through a supplementary
Multibillion dollar boost. Japanese leaders lay out their multibillion dollar boost. Japanese leaders lay out their master plan for revitalizing the economy. Welcome to nhk world newsline. Japanese government is following through on its promises to give the economy a shot in the arm. Government leaders have agreed on a stimulus package worth 115 billion. They hope to boost growth by 2 . The government will allocate the funds to three areas. More than 40 billion will go to rebuilding after the earthquake and tsunami and to disaster prevention. Workers will use the funds repairing infrastructure such as tunnels and bridges. About 35 billion will be spent on measures to ensure security and revitalized communities. And about 35 billion will be spent on driving growth. Some of that will support business ventures. Other funds will go into promoting joint Research Projects between universities and companies. Stimulus package plus spending by local governments and the private sector will add u
This article reviews the essential regulatory considerations surrounding medicines and medical devices in Japan, including clinical trials and marketing authorisations.